Preview

Oncohematology

Advanced search

Combination of multiple myeloma and chronic idiopathic myelofibrosis: a case report

https://doi.org/10.17650/1818-8346-2009-0-3-61-68

Abstract

Case report of a patient with simultaneously developed lymphoid and myeloid hemoblastosis is presented. Diagnosis of multiple myeloma and chronic idiopathic myelofibrosis are confirmed by complete blood count, myelogramm, trephinebiopsy, immunohistochemical, cytogenetic, biochemical and radiological examination. Complete remission of multiple myeloma was achieved after 7 courses «VAD» and 11-weeks treatment with recombinant erythropoietin beta with subsequent maintenance therapy courses of bortezomib and reaferon. However, chronic idiopathic myelofibrosis was progressed to acute myeloid leukemia. Disease stabilization was achieved with 3 therapy courses «5+2».

About the Authors

N. A. Romanenko
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



S. S. Bessmeltsev
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



V. I. Rugal
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



N. A. Potichonova
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



M. N. Zenina
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



K. M. Abdulkadirov
Russian Research Institute of Hematology and Transfusiology
Russian Federation

St-Petersburg



References

1. Андреева Н.Е. Миеломная болезнь. Руководство по гематологии в 2 т. Под ред. А.И. Воробьева. М.: Медицина, 1985. с. 292—308.

2. Созин С.Е., Салогуб Г.Н. Случай развития острого мегакариобластного лейкоза (М7) у больной с клинической ремиссией множественной миеломы. Клин онкогематол 2008;(2):141—4.

3. Takada M., Umeda M., Shikoshi K., Shirai T. IgG lambda-type multiple myeloma associated with myelofibrosis accompanied by thrombocytosis. Rinsho Ketsueki 1991;32(9):1001—5.

4. Dührsen U., Uppenkamp M., Meusers P. et al. Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias. Blut 1988;56(3): 97—102.

5. Kawauchi K., Mori H., Sugiyama H. et al. Multiple myeloma with coexistent myelofibrosis: Improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolon. Jpn J Med 1991;30(5):483—6.

6. Krzyzaniak R.L., Buss D.H., Cooper M.R., Wells H.B. Marrow fibrosis and multiple myeloma. Am J Clin Pathol 1988;89(1):63—8.

7. Vandermolen L., Rice L., Lynch E.C. Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome. Am J Med 1985;79(3):297—302.

8. Бессмельцев С.С., Абдулкадыров К.М. Множественная миелома. Гематология: Новейший справочник. Под ред. К.М. Абдулкадырова. М.: Эксмо; СПб.: Сова; 2004. с. 593—665.

9. Вотякова О.М., Демина Е.А. Множественная миелома. Клиническая Онкогематология. Руководство для врачей. Под ред. М.А. Волковой. М.: Медицина, 2007. с. 847—73.

10. Андреева Н.Е., Балакирева Т.В. Множественная миелома. Руководство по гематологии в 3 т. Под ред. А.И. Воробьева. М.: Ньюдиамед, 2003. с. 151—73.

11. Groga G.M., Van Camp B., Kyle R.A. et al. Plasma cell neoplasms. In: Pathology and Genetics: Tumors of Hematopoietic and Lymphoid Tissues. E.S. Jaffe, N.L. Harris, Y. Stein et al. eds. Lyon: IARC Press, 2001. р. 142—56.

12. Huang Y.W., Hamilton A., Arnuk O.J. et al. Current drug therapy for multiple myeloma. Drugs 1999;57(4):485.

13. Бессмельцев С.С. Хронический идиопатический миелофиброз. Гематология. Новейший справочник. Под ред. К.М. Абдулкадырова. М.: Эксмо; СПб.: Сова, 2004. с. 556—71.

14. Демидова А.В. Хронический идиопатический миелофиброз. Клиническая Онкогематология. Руководство для врачей. Под ред. М.А. Волковой. М.: Медицина, 2007. с. 616—30.

15. Абдулкадыров К.М. Хронический идиопатический миелофиброз. Клиническая гематология. Справочник. СПб.: Питер, 2006. с. 181—6.

16. Laszlo J., Huang A.T. Semin Hematol 1975;2:403.

17. Colagrande M., Di Ianni M., Coletti G. et al. Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving. thalidomide therapy. Int J Hematol 2009;89(1):76—9.

18. Zhang Y., Li L., Nie L. et al. Clinical study on relationship between JAK2 V617F mutation and chronic myeloproliferative disorders. Zhonghua Xue Ye Xue Za Zhi 2008;29(2):105—9.

19. Abildgaard N., Bendix-Hansen K., Kristensen J.E. et al. Bone marrow fibrosis and disease activity in multiple myeloma monitored by the aminoterminal propeptide of procollagen III in serum. Br J Haematol 1997;99(3):641—8.

20. Subramanian R., Basu D., Dutta T.K. Significance of bone marrow fibrosis in multiple myeloma. Pathology 2007;39(5):512—5.

21. Vedrine L., Boucher E., Samson T. et al. Mieloid pseudo-splenomegaly in patient with a myeloma. Press Med 2002;31:1846—8.

22. Stevenson J.P., Schwarting R., Schuster S.J. Analysis of clonality using X-linked polymorphisms in a patient with multiple myeloma and myelofibrosis. Am J Hematol 1998;59(1):79—82.

23. de la Serna J., Bornstein R., Lahuerta-Palacios J.J. The use of an expanded circulating hematopoietic progenitor cell pool associated with bone marrow fibrosis for the support of autologous transplantation in IgD multiple myeloma. Bone Marrow Transplant 1997;19(10):1033—6.

24. Kanoh T., Okuma M. IgD (lambda) multiple myeloma associated with myelofibrosis: an isolated case of nuclear physicist. Rinsho Ketsueki 1996;37(3):244—8.

25. McCluggage W.G., Jones F.G, Hull D. et al. Sclerosing IgA multiple myeloma. Acta Haematol 1995;94(2):98—101.

26. Murayama T., Matsui T., Hayashi Y. et al. Plasma cell leukemia with myelofibrosis. Ann Hematol 1994;69(3): 151—2.

27. Абдулкадыров К.М. Множественная миелома. Клиническая гематология. Справочник. СПб.: Питер, 2006. с. 220—41.


Review

For citations:


Romanenko N.A., Bessmeltsev S.S., Rugal V.I., Potichonova N.A., Zenina M.N., Abdulkadirov K.M. Combination of multiple myeloma and chronic idiopathic myelofibrosis: a case report. Oncohematology. 2009;(3):61-68. (In Russ.) https://doi.org/10.17650/1818-8346-2009-0-3-61-68

Views: 180


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)